The protective role of melatonin in the course of UV exposure;Ochronna rola melatoniny podczas działania promieniowania UV

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 23-27

  Izykowska, Ilona ^a   Piotrowska, Aleksandra ^a   Podhorska Okołów, Marzena ^a   Cegielski, Marek ^a   Zabel, Maciej ^a,b   Dzięgiel, Piotr ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Katedra i Zakład Histologii i Embriologii Im Karola Marcinkowskiego W Poznaniu ^*  (Poland)

Author keywords

Eye; Melatonin; Skin; UV radiation

Indexed keywords

MELATONIN; MELATONIN RECEPTOR; RADIOPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; DRUG EFFECT; HUMAN; KERATINOCYTE; METABOLISM; PHYSIOLOGY; PINEAL BODY; RADIATION EXPOSURE; RADIATION INJURY; RAT; SKIN; ULTRAVIOLET RADIATION;

ANIMALS; HUMANS; KERATINOCYTES; MELATONIN; PINEAL GLAND; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, MELATONIN; SKIN; ULTRAVIOLET RAYS;

EID: 38949162025     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abdulghani A.A., Sherr A., Shirin S et al: Effect of topical creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretitonin on the ultrastructure of normal skin. Dis. Manag., 1998; 1: 136-141
2. Anwar M.M., Moustafa M.A.: The effect of melatonin on eye lens of rats exposed to ultraviolet radiation. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2001; 129: 57-63
3. Bangha E., Elsner P., Kistler G.S.: Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch. Deramatol. Res., 1996; 288: 522-526
4. Bangha E., Elsner P., Kistler G.S.: Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Influence of the application time point. Dermatology, 1997; 195: 248-252
5. Bardak Y.: Effect of melatonin on lenticular calcium and magnesium in rats exposed to ultraviolet radiation. Ophthalmologica, 2000; 214: 350-353
6. Bernerd F., Asselineau D.: UVA exposure of human skin reconstructed in vitro induces apoptosis of dermal fibroblasts: subsequent connective tissue repair and implications in photoaging. Cell Death Differ., 1998; 5: 792-802
7. Bernerd F., Asselineau D.: Successive alteration and recovery of epidermal differentiation and morphogenesis after specific UVB-damages in skin reconstructed in vitro. Dev. Biol., 1997; 183: 123-138
8. CiuffiM., Pisanello M., Pagliai G., Raimondi L., Franchi-Micheli S., Cantore M., Mazzetti L., Failli P.: Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure. J. Photochem. Photobiol. B, 2003; 71: 59-68
9. Dreher F., Denig N., Gabard B., Schwindt D.A., Maibach H.I.: Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatology, 1999; 198: 52-55
10. Dreher F, Gabard B., Schwindt D.A., Maibach H.I.: Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: A human study in vivo. Br. J. Dermatol., 1998; 139: 332-339
11. Dubley V., Mishra D., Asthana A., Jain N.K.: Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials, 2006; 27: 3491-3496
12. Fic M., Podhorska-Okolow M., Dziegiel P., Gebarowska E., Wysocka T., Drag-Zalesinska M., Zabel M.: Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2). In Vivo, 2007; 21: 513-518
13. Fischer T., Bangha E., Elsner P., Kistler G.S.: Suppression of UV-induced erythema by topical treatment with melatonin. Influence of the application time point. Biol. Signals Recept., 1999; 8: 132-135
14. Fischer T.W., Greif C., Fluhr J.W., Wigger-Alberti W., Elsner P.: Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution. Skin Pharmacol. Physiol., 2004; 17: 190-194
15. Fischer T.W., Scholz G., Knöll B., Hipler U.C., Elsner P.: Melatonin suppresses reactive oxygen species induced by UV irradiation in leukocytes. J. Pineal Res., 2004; 37: 107-112
16. Fischer T.W., Sweatman T.W., Semak I., Sayre R.M., Wortsman J., Slominski A.: Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J., 2006; 20: 1564-1566
17. Fischer T.W., Zbytek B., Sayre R.M., Apostolov E.O., Basnakian A.G., Sweatman T.W., Wortsman J., Elsner P., Slominski A.: Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J. Pineal Res., 2006; 40: 18-26
18. Iuvone P.M., Tosini G., Pozdeyev N., Haque R., Klein D.C., Chaurasia S.S.: Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina. Prog. Retin. Eye Res., 2005; 24: 433-456
19. Lee K.S., Lee W.S., Suh S.I., Kim S.P., Lee S.R., Ryoo Y.W., Kim B.C.: Melatonin reduces ultraviolet-B induced cell damages and polyamine levels in human skin fibroblasts in culture. Exp. Mol. Med., 2003; 35: 263-268
20. Luchetti F., Canonico B., Curci R., Battistelli M., Mannello F., Papa S., Tarzia G., Falcieri E.: Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. J. Pineal Res., 2006; 40: 158-167
21. Maharaj D.S., Anoopkumar-Dukie S., Glass B.D., Antunes E.M., Lack B., Walker R.B., Daya S.: The identification of the UV degradants of melatonin and their ability to scavenge free radicals. J. Pineal Res., 2002; 32: 257-261
22. Maharaj D.S., Molell H., Antunes E.M., Maharaj H., Maree D.M., Nyokong T., Glass B.D., Daya S.: Melatonin generates singlet oxygen on laser irradiation but acts as a quencher when irradiated by lamp photolysis. J. Pineal Res., 2005; 38: 153-156
23. Marchiafava P.L., Longoni B.: Melatonin as an antioxidant in retinal photoreceptors. J. Pineal Res., 1999; 26: 184-189
24. Mass P., Hoffmann K., Gambichler T., Altmeyer P., Mannherz H.G.: Premature keratinocyte death and expression of marker proteins of apoptosis in human skin after UVB exposure. Arch. Dermatol. Res., 2003; 295: 71-79
25. Meyer P., Pache M., Loeffler K.U., Brydon L., Jockers R., Flammer J., Wirz-Justice A., Savaskan E.: Melatonin MT-1-receptor immunoreactivity in the human eye. Br. J. Ophthalmol., 2002; 86: 1053-1057
26. Reiter R.J.: Melatonin: clinical relevance. Best Pract. Res. Clin. Endocrinol. Metab., 2003; 17: 273-285
27. Ryoo Y.W., Suh S.I., Mun K.C., Kim B.C., Lee K.S.: The effects of the melatonin on ultraviolet-B irradiated cultured dermal fibroblasts. J. Dermatol. Sci., 2001; 27: 162-169
28. Saija A., Tomaino A., Trombetta D., Pellegrino M.L., Tita B., Caruso S., Castelli F.: Interaction of melatonin with model membranes and possible implications in its photoprotective activity. Eur. J. Pharm. Biopharm., 2002; 53: 209-215
29. Savaskan E., Wirz-Justice A., Olivieri G., Pache M., Kräuchi K., Brydon L., Jockers R., Müller-Spahn F., Meyer P.: Distribution of melatonin MT1 receptor immunoreactivity in human retina. J. Histochem. Cytochem., 2002; 50: 519-526
30. Scher J., Wankiewicz E., Brown G.M., Fujieda H.: MT1 melatonin receptor in the human retina: expression and localization. Invest. Ophthalmol. Vis. Sci., 2002; 43: 889-897
31. Siu A.W., Maldonado M., Sanchez-Hidalgo M., Tan D.X., Reiter R.J.: Protective effects of melatonin in experimental free radical-related ocular diseases. J. Pineal Res., 2006; 40: 101-109
32. Slominski A., Fischer T.W., Zmijewski M.A., Wortsman J., Semak I., Zbytek B., Slominski R.M., Tobin D.J.: On the role of melatonin in skin physiology and pathology. Endocrine, 2005; 27: 137-148
33. Slominski A., Pisarchik A., Semak I., Sweatman T., Wortsman J., Szczesniewski A., Slugocki G., McNulty J., Kauser S., Tobin D.J., Jing C., Johansson O.: Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J., 2002; 16: 896-898
34. Slominski A., Pisarchik A., Zbytek B., Tobin D.J., Kauser S., Wortsman J.: Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J. Cell. Physiol., 2003; 196: 144-153
35. Slominski A., Wortsman J., Tobin D.J.: The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J., 2005; 19: 176-194
36. Tan D.X., Reiter R.J., Manchester L.C., Yang M.T., El-Sawi M., Sainz R.M., Mayo J.C., Kohen R., Allegra M., Hardeland R.: Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem., 2002; 2: 181-197
37. Tursilli R., Casolari A., Iannuccelli V., Scalia S: Enhancement of melatonin photostability by encapsulation in lipospheres. J. Pharm. Biomed. Anal., 2006; 40: 910-914
38. von Kobyletzki G., Heine O., Stephan H., Pieck C., Stücker M., Hoffmann K., Altmeyer P., Mannherz H.G.: UVA1 irradiation induces deoxyribonuclease dependent apoptosis in cutaneous T-cell lymphoma in vivo. Photodermatol. Photoimmunol. Photomed., 2000; 16: 271-277
39. Yildirim N., Õzer A., Inal M., Angin K., Yurdakul S.: The effect of N-acetyl serotonin on ultraviolet-radiation induced cataracts in rats. Ophthalmologica, 2003; 217: 148-153